TickerFacts.

Guardant Health, Inc. (GH): Free Cash Flow

Operating cash flow minus capital expenditures for the same annual period and currency, computed by TickerFacts from the filed figures. A simple proxy, not a reported figure; a year without both inputs is left out.

-$233.07M
Year ended 2025-12-31
-$240.72M
Trailing 12 months to 2026-06-30
2016-12-31: -$38.48M2017-12-31: -$78.92M2018-12-31: -$92.39M2019-12-31: -$65.85M2020-12-31: -$140.10M2021-12-31: -$284.05M2022-12-31: -$386.92M2023-12-31: -$345.46M2024-12-31: -$274.94M2025-12-31: -$233.07M-$233.07M
2016-12-31 Free Cash Flow (USD) 2025-12-31
Period endedFree Cash FlowChange YoYSource filing
2025-12-31-$233.07Mn/m2026-02-19, From 2025-01-01
2024-12-31-$274.94Mn/m2026-02-19, From 2024-01-01
2023-12-31-$345.46Mn/m2026-02-19, From 2023-01-01
2022-12-31-$386.92Mn/m2025-02-20, From 2022-01-01
2021-12-31-$284.05Mn/m2024-02-22, From 2021-01-01
2020-12-31-$140.10Mn/m2023-02-23, From 2020-01-01
2019-12-31-$65.85Mn/m2022-02-24, From 2019-01-01
2018-12-31-$92.39Mn/m2021-02-25, From 2018-01-01
2017-12-31-$78.92Mn/m2020-03-02, From 2017-01-01
2016-12-31-$38.48Mn/a2019-03-19, From 2016-01-01

Free Cash Flow at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedFree Cash FlowChange YoY
Guardant Health, Inc. (GH)2025-12-31-$233.07Mn/m
Caris Life Sciences, Inc. (CAI)2025-12-31$66.89Mn/m
Veracyte, Inc. (VCYT)2025-12-31$126.63M+98.5%
Natera, Inc. (NTRA)2025-12-31$109.11M+57.6%
Fortrea Holdings Inc. (FTRE)2025-12-31$88.30M-62.8%
Castle Biosciences Inc (CSTL)2025-12-31$28.33M-22.5%
Fulgent Genetics, Inc. (FLGT)2025-12-31-$124.21Mn/m
BillionToOne, Inc. (BLLN)2025-12-31$15.71Mn/m
GRAIL, Inc. (GRAL)2025-12-31-$299.92Mn/m

Compare GH, CAI, VCYT, NTRA side by side · Screen every company in Services-Medical Laboratories ↗